FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2517621176> ?p ?o ?g. }

• W2517621176 abstract "The standard of care for HIV treatment is a three-drug regimen consisting of two nucleoside reverse transcriptase inhibitors (NRTIs) and either a non-nucleoside reverse transcriptase inhibitor, a protease inhibitor (PI) or an integrase strand transfer inhibitor. Darunavir boosted with ritonavir (DRV/r) is the only preferred PI in the US Department of Health and Human Services (DHHS) HIV treatment guidelines for antiretroviral-naïve patients, recommended in combination with tenofovir/emtricitabine for antiretroviral-naïve patients. For treatment-experienced and certain antiretroviral-naïve patients, abacavir and lamivudine (ABC/3TC) in combination with DRV/r is considered an effective and tolerable alternative, despite limited research on the effectiveness of this particular combination. This study evaluated virologic outcomes in treatment-experienced patients taking ABC/3TC + DRV/r compared to treatment-experienced patients taking ABC/3TC with any other PI.Treatment-experienced HIV-infected patients initiating their first regimen containing ABC/3TC in combination with any PI in the year 2005 or later were selected from the Observational Pharmaco-Epidemiology Research and Analysis (OPERA®) cohort, a prospective observational cohort reflecting routine medical care. Viral load measurements taken during follow-up were compared between patients taking ABC/3TC + DRV/r and ABC/3TC with a PI other than DRV/r. Logistic regression models were fit to assess the association between regimen exposure and viral load suppression.A total of 151 patients initiating ABC/3TC + DRV/r and 525 patients initiating ABC/3TC + a non-darunavir PI were included. Patients in both treatment groups had comparable clinical indicators (viral load, CD4) at baseline. A regimen of ABC/3TC + DRV/r was more likely to be prescribed in the later years of the study period, leading to a shorter median follow-up in the DRV/r treatment group (as-treated analysis: 14 vs. 17 months, p = 0.04; intent-to-treat analysis: 33 vs. 68 months, p < 0.001). Multivariable logistic regression models accounting for year of regimen initiation, among other factors, indicated no statistically significant differences in achieving an undetectable viral load for patients taking DRV/r with ABC/3TC compared with other PIs, both in the as-treated (odds ratio [95 % confidence interval]: 0.84 [0.53-1.34]) and intent-to-treat analyses (0.82 [0.48-1.40]). Patients in both treatment groups also showed similar reductions in viral load (median darunavir vs. non-darunavir: -23.0 vs. -23.0 copies/mL; p = 0.72) and gains in CD4 T cell counts (median darunavir vs. non-darunavir: 106 vs. 108 cells/mm3; p = 0.59] while being treated with the regimen of interest.Patients receiving ABC/3TC + DRV/r appear to experience similar treatment benefit to patients taking ABC/3TC with other PIs in terms of achieving suppression, as well as absolute reductions in viral load and CD4 lymphocyte gains." @default.
• W2517621176 created "2016-09-16" @default.
• W2517621176 creator A5009518467 @default.
• W2517621176 creator A5015648859 @default.
• W2517621176 creator A5026216302 @default.
• W2517621176 creator A5032195974 @default.
• W2517621176 creator A5042040728 @default.
• W2517621176 creator A5058707616 @default.
• W2517621176 creator A5065085249 @default.
• W2517621176 creator A5073100933 @default.
• W2517621176 creator A5078721914 @default.
• W2517621176 creator A5087319059 @default.
• W2517621176 date "2016-09-01" @default.
• W2517621176 modified "2023-09-24" @default.
• W2517621176 title "Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice" @default.
• W2517621176 cites W1971168783 @default.
• W2517621176 cites W1972659744 @default.
• W2517621176 cites W1983697728 @default.
• W2517621176 cites W1996282296 @default.
• W2517621176 cites W1996311973 @default.
• W2517621176 cites W1997259446 @default.
• W2517621176 cites W2012794817 @default.
• W2517621176 cites W2022017978 @default.
• W2517621176 cites W2052276948 @default.
• W2517621176 cites W2061212708 @default.
• W2517621176 cites W2068825266 @default.
• W2517621176 cites W2076339980 @default.
• W2517621176 cites W2078975498 @default.
• W2517621176 cites W2090157578 @default.
• W2517621176 cites W2103513664 @default.
• W2517621176 cites W2104710716 @default.
• W2517621176 cites W2110169072 @default.
• W2517621176 cites W2111884657 @default.
• W2517621176 cites W2118990998 @default.
• W2517621176 cites W2119628015 @default.
• W2517621176 cites W2139772076 @default.
• W2517621176 cites W2149051049 @default.
• W2517621176 doi "https://doi.org/10.1007/s40261-016-0456-1" @default.
• W2517621176 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5209413" @default.
• W2517621176 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27587070" @default.
• W2517621176 hasPublicationYear "2016" @default.
• W2517621176 type Work @default.
• W2517621176 sameAs 2517621176 @default.
• W2517621176 citedByCount "3" @default.
• W2517621176 countsByYear W25176211762017 @default.
• W2517621176 countsByYear W25176211762018 @default.
• W2517621176 crossrefType "journal-article" @default.
• W2517621176 hasAuthorship W2517621176A5009518467 @default.
• W2517621176 hasAuthorship W2517621176A5015648859 @default.
• W2517621176 hasAuthorship W2517621176A5026216302 @default.
• W2517621176 hasAuthorship W2517621176A5032195974 @default.
• W2517621176 hasAuthorship W2517621176A5042040728 @default.
• W2517621176 hasAuthorship W2517621176A5058707616 @default.
• W2517621176 hasAuthorship W2517621176A5065085249 @default.
• W2517621176 hasAuthorship W2517621176A5073100933 @default.
• W2517621176 hasAuthorship W2517621176A5078721914 @default.
• W2517621176 hasAuthorship W2517621176A5087319059 @default.
• W2517621176 hasBestOaLocation W25176211761 @default.
• W2517621176 hasConcept C126322002 @default.
• W2517621176 hasConcept C142462285 @default.
• W2517621176 hasConcept C159047783 @default.
• W2517621176 hasConcept C2522874641 @default.
• W2517621176 hasConcept C2777869810 @default.
• W2517621176 hasConcept C2779182219 @default.
• W2517621176 hasConcept C2779298103 @default.
• W2517621176 hasConcept C2779465607 @default.
• W2517621176 hasConcept C2779502633 @default.
• W2517621176 hasConcept C2779778239 @default.
• W2517621176 hasConcept C2780404665 @default.
• W2517621176 hasConcept C2780593183 @default.
• W2517621176 hasConcept C2781143361 @default.
• W2517621176 hasConcept C2781413609 @default.
• W2517621176 hasConcept C2781432083 @default.
• W2517621176 hasConcept C2993143319 @default.
• W2517621176 hasConcept C3013748606 @default.
• W2517621176 hasConcept C71924100 @default.
• W2517621176 hasConcept C98274493 @default.
• W2517621176 hasConceptScore W2517621176C126322002 @default.
• W2517621176 hasConceptScore W2517621176C142462285 @default.
• W2517621176 hasConceptScore W2517621176C159047783 @default.
• W2517621176 hasConceptScore W2517621176C2522874641 @default.
• W2517621176 hasConceptScore W2517621176C2777869810 @default.
• W2517621176 hasConceptScore W2517621176C2779182219 @default.
• W2517621176 hasConceptScore W2517621176C2779298103 @default.
• W2517621176 hasConceptScore W2517621176C2779465607 @default.
• W2517621176 hasConceptScore W2517621176C2779502633 @default.
• W2517621176 hasConceptScore W2517621176C2779778239 @default.
• W2517621176 hasConceptScore W2517621176C2780404665 @default.
• W2517621176 hasConceptScore W2517621176C2780593183 @default.
• W2517621176 hasConceptScore W2517621176C2781143361 @default.
• W2517621176 hasConceptScore W2517621176C2781413609 @default.
• W2517621176 hasConceptScore W2517621176C2781432083 @default.
• W2517621176 hasConceptScore W2517621176C2993143319 @default.
• W2517621176 hasConceptScore W2517621176C3013748606 @default.
• W2517621176 hasConceptScore W2517621176C71924100 @default.
• W2517621176 hasConceptScore W2517621176C98274493 @default.
• W2517621176 hasFunder F4320312382 @default.
• W2517621176 hasLocation W25176211761 @default.
• W2517621176 hasLocation W25176211762 @default.
• W2517621176 hasLocation W25176211763 @default.

• next